Indeed, increased expression of apoptotic markers and decreased cellular proliferation were observed in IM-resistant GIST T-1R cells treated with IM in combination with the CLDN1 inhibitor PDS-0330 or after CLDN1 knockdown (Figure 2 and Figure 3). Here, CLDN1 is linked to gastrointestinal stromal tumor.